A detailed history of Redmond Asset Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Redmond Asset Management, LLC holds 4,025 shares of NVO stock, worth $420,854. This represents 0.16% of its overall portfolio holdings.

Number of Shares
4,025
Previous 4,025 -0.0%
Holding current value
$420,854
Previous $574,000 16.55%
% of portfolio
0.16%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$102.11 - $135.92 $23,281 - $30,989
-228 Reduced 5.36%
4,025 $516,000
Q3 2023

Oct 24, 2023

BUY
$90.94 - $199.54 $193,429 - $424,421
2,127 Added 100.05%
4,253 $386,000
Q3 2022

Nov 10, 2022

BUY
$95.28 - $116.93 $95 - $116
1 Added 0.05%
2,126 $212,000
Q2 2022

Aug 10, 2022

BUY
$103.24 - $121.81 $103 - $121
1 Added 0.05%
2,125 $237,000
Q4 2021

Feb 04, 2022

BUY
$95.88 - $117.08 $203,649 - $248,677
2,124 New
2,124 $238,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $236B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Redmond Asset Management, LLC Portfolio

Follow Redmond Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmond Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmond Asset Management, LLC with notifications on news.